Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KQB548 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on KQB548 (BAY 3771249), a putative KRAS G12D inhibitor (Oct 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KQB548 | KQ-B548|KQ B548|BAY3771249|BAY 3771249|BAY-3771249 | KRAS G12D Inhibitor 25 | Limited information is currently available on KQB548 (BAY 3771249), a putative KRAS G12D inhibitor (Oct 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07207707 | Phase I | KQB548 | A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies | Recruiting | USA | 0 |